Free Trial
NASDAQ:BNR

Burning Rock Biotech (BNR) Stock Price, News & Analysis

Burning Rock Biotech logo
$8.91 +0.31 (+3.60%)
Closing price 08/26/2025 03:59 PM Eastern
Extended Trading
$8.82 -0.10 (-1.07%)
As of 08/26/2025 04:28 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Burning Rock Biotech Stock (NASDAQ:BNR)

Key Stats

Today's Range
$8.77
$9.30
50-Day Range
$3.06
$10.17
52-Week Range
$2.18
$11.12
Volume
40,058 shs
Average Volume
44,785 shs
Market Capitalization
$95.87 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Burning Rock Biotech Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
13th Percentile Overall Score

BNR MarketRank™: 

Burning Rock Biotech scored higher than 13% of companies evaluated by MarketBeat, and ranked 294th out of 304 stocks in the business services sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Burning Rock Biotech.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Burning Rock Biotech is -4.71, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Burning Rock Biotech is -4.71, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Burning Rock Biotech has a P/B Ratio of 1.21. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Burning Rock Biotech's valuation and earnings.
  • Percentage of Shares Shorted

    0.48% of the float of Burning Rock Biotech has been sold short.
  • Short Interest Ratio / Days to Cover

    Burning Rock Biotech has a short interest ratio ("days to cover") of 1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Burning Rock Biotech has recently increased by 10.46%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Burning Rock Biotech does not currently pay a dividend.

  • Dividend Growth

    Burning Rock Biotech does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.48% of the float of Burning Rock Biotech has been sold short.
  • Short Interest Ratio / Days to Cover

    Burning Rock Biotech has a short interest ratio ("days to cover") of 1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Burning Rock Biotech has recently increased by 10.46%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Burning Rock Biotech has a news sentiment score of 1.08. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Business Services companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for Burning Rock Biotech this week, compared to 0 articles on an average week.
  • MarketBeat Follows

    1 people have added Burning Rock Biotech to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Burning Rock Biotech insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    30.30% of the stock of Burning Rock Biotech is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 30.03% of the stock of Burning Rock Biotech is held by institutions.

  • Read more about Burning Rock Biotech's insider trading history.
Receive BNR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Burning Rock Biotech and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

BNR Stock News Headlines

Burning Rock Reports First Quarter 2025 Financial Results
The Robotics Revolution has arrived … and one $7 stock could take off as a result.
Something big is brewing in Washington. According to my research, an executive order from President Trump could be just weeks away. And it holds the potential to trigger one of the most explosive tech booms in US history. At the center of it all? Robots. Not the kind that clean your house or pour you coffee. But the kind that could reshape entire industries, add $1.2 trillion per year to the US economy, and affect 65 million American lives — just in the next year.tc pixel
Burning Rock Announces Results of 2024 Annual General Meeting
Burning Rock Biotech’s Strategic Growth and Financial Results
See More Headlines

BNR Stock Analysis - Frequently Asked Questions

Burning Rock Biotech's stock was trading at $6.75 at the start of the year. Since then, BNR stock has increased by 32.0% and is now trading at $8.91.

Burning Rock Biotech Limited Sponsored ADR (NASDAQ:BNR) issued its quarterly earnings data on Friday, June, 6th. The company reported ($0.17) EPS for the quarter. The company had revenue of $18.34 million for the quarter. Burning Rock Biotech had a negative trailing twelve-month return on equity of 38.33% and a negative net margin of 45.41%.

Burning Rock Biotech's stock reverse split on the morning of Wednesday, May 15th 2024.The 1-10 reverse split was announced on Wednesday, May 15th 2024. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, May 15th 2024. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

Burning Rock Biotech (BNR) raised $196 million in an IPO on Friday, June 12th 2020. The company issued 13,500,000 shares at $13.50-$15.50 per share. Morgan Stanley, BofA Securities and Cowen acted as the underwriters for the IPO and CMBI and Tiger Brokers were co-managers.

Shares of BNR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Burning Rock Biotech investors own include Tesla (TSLA), NVIDIA (NVDA), Intel (INTC), Vertex Pharmaceuticals (VRTX), HubSpot (HUBS), NIO (NIO) and Alibaba Group (BABA).

Company Calendar

Last Earnings
6/06/2025
Today
8/26/2025
Next Earnings (Estimated)
8/28/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Technology Services
Sub-Industry
Healthcare
Current Symbol
NASDAQ:BNR
CIK
1792267
Fax
N/A
Employees
1,390
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($1.89)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$47.49 million
Net Margins
-45.41%
Pretax Margin
-43.68%
Return on Equity
-38.33%
Return on Assets
-25.34%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
3.02
Quick Ratio
2.76

Sales & Book Value

Annual Sales
$523.28 million
Price / Sales
0.18
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$7.39 per share
Price / Book
1.21

Miscellaneous

Outstanding Shares
10,761,000
Free Float
7,500,000
Market Cap
$95.88 million
Optionable
Not Optionable
Beta
0.83

Social Links

7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

This page (NASDAQ:BNR) was last updated on 8/27/2025 by MarketBeat.com Staff
From Our Partners